A Phase II Open-Label Study of Bermekimab in Patients with Hidradenitis Suppurativa Shows Resolution of Inflammatory Lesions and Pain - Concepedia

Concepedia

Publication | Closed Access

A Phase II Open-Label Study of Bermekimab in Patients with Hidradenitis Suppurativa Shows Resolution of Inflammatory Lesions and Pain

85

Citations

29

References

2020

Year

Alice B. Gottlieb, Nicola E. Natsis, Francisco A. Kerdel, Seth Forman, Edgar R. Gonzalez, Gilberto Jimenez, Liliam Hernández, Jessica Kaffenberger, Giancarlo Guido, Kathryn Jean Lucas,

Journal of Investigative Dermatology

Inflammatory LesionsPathologyClinical DermatologyDermatologySclerodermaMedicine

References

	Year	Citations

Page 1